Save up -80% on Adalimumab
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Humira
|$5,242.87||1 carton (2 pens) 40mg/0.8ml|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Humira coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Adalimumab every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Adalimumab volume of distribution
The estimated apparent volume of distribution (V/F) is 12.4 l. Given that adalimumab bioavailability (F) is 64% 12, the adalimumab volume of distribution (V) in our study would be 6.9 l, a value which is slightly higher than the value reported in the adalimumab approval document (4.7–6.0 l) 12.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Adalimumab
Adalimumab is a human monoclonal antibody against TNF-alpha. It is produced by recombinant DNA technology using a mammalian cell expression system. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.
Adalimumab mechanism of action
Adalimumab binds to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also lyses surface TNF expressing cells in vitro in the presence of complement.
Dosage forms of Adalimumab
|Injection, solution||subcutaneous||40 mg/.8mL|
Ig gamma-1 chain C region
Humans and other mammals
Indication of Adalimumab
For treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn’s disease.
Toxicity of Adalimumab
Patients treated with Humira are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. Humira should be discontinued if a patient develops a serious infection or sepsis. Reported infections include: Active tuberculosis, including reactivation of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease. Patients should be tested for latent tuberculosis before Humira use and during therapy. Treatment for latent infection should be initiated prior to Humira use. Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Adalimumab on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.